Oppenheimer & Co’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.1M Buy
5,807
+3,422
+143% +$1.13M 0.02% 611
2026
Q2
$870K Sell
2,385
-246
-9% -$92.3K 0.01% 1002
2026
Q1
$741K Sell
2,631
-223
-8% -$64.7K 0.01% 1013
2025
Q4
$844K Sell
2,854
-3,065
-52% -$924K 0.01% 872
2025
Q3
$1.46M Sell
5,919
-8,126
-58% -$1.64M 0.02% 721
2025
Q2
$2.19M Buy
14,045
+10,160
+262% +$1.08M 0.03% 546
2025
Q1
$306K Sell
3,885
-12,565
-76% -$1.33M ﹤0.01% 1264
2024
Q4
$1.52M Buy
16,450
+4,874
+42% +$381K 0.02% 639
2024
Q3
$592K Sell
11,576
-24,199
-68% -$1.25M 0.01% 979
2024
Q2
$2.05M Buy
+35,775
New +$1.8M 0.03% 528

Other funds holding CLS

Oppenheimer & Co's CLS Position: Q3 2026 in Review

Oppenheimer & Co increased its Celestica (CLS) stake by 143% in Q3 2026, buying an estimated $1.13M and bringing the position to 5,807 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #611.

Oppenheimer & Co first reported a position in CLS in Q2 2024 and has held it in 10 quarters since. The position peaked at $2.19M in Q2 2025. 357 funds tracked by Wall St. Rank hold CLS as of Q3 2026.

  • Oppenheimer & Co held 5,807 shares of Celestica worth $2.1M as of Q3 2026.
  • Oppenheimer & Co bought 3,422 Celestica shares in Q3 2026, an estimated $1.13M.
  • Celestica made up 0.02% of Oppenheimer & Co's portfolio in Q3 2026, its #611 holding.
  • Oppenheimer & Co first reported a position in Celestica in Q2 2024 and has held it in 10 quarters since.
  • Oppenheimer & Co's Celestica position peaked at $2.19M in Q2 2025.
  • 357 funds tracked by Wall St. Rank held Celestica as of Q3 2026.

Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.